
Biogen (NASDAQ: BIIB) has announced that the European Medicines Agency (EMA) has accepted its investigational treatment for Alzheimer’s disease, aducanumab, …

The European Medicines Agency (EMA) has launched its new PRIME (priority medicines) scheme, which aims to strengthen support to medicines …

The PM Society is set to expand its reach across pharma and service firms through the new appointments of co-chairs …
The times they are a changin’ and not just according to Bob Dylan. It’s hard to go to any UK …
Marketing is defined in the New English Dictionary as all the processes involved in moving goods from the producer to …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

